Get started

CureVac N.V

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

CVAC chart

Key stats

Market capitalization
2.048BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.34USD

About CureVac N.V

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Alexander Zehnder
Website
curevac.com
Headquarters
Tübingen
Employees
1.049K
Founded
2000
ISIN
NL0015436031

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.

Ideas

On Pharmaceutical Cartel. 🇺🇸 🇪🇺 NASDAQ:CVAC I hope you have enjoyed the global lie called 'Democracy' spread by US and EU and enjoy the death of your friends and family, It was only to fill the pockets of those who donate money to political campaigns. Headlines: Nov 10, 2016: Welcome To 2030: I Own Nothing, Have No Privacy
Long
22
CVAC, BNTX & MRNA comparisonCureVac N.V. (CVAC) has filed a patent infringement lawsuit in Germany against BioNTech to assert the company's intellectual property rights which contributed to COVID-19 vaccine development. The company said the CureVac intellectual property portfolio protects multiple inventions that are considere
Long
1
Curevac is completely oversold I see that this stock has been very hit lately, the pattern I see tells me that a reversal may be close and that it is completely oversold. I see that it can return maximum to about 40 dollars in the following days or weeks.
Long
2
CVAC Long Position Idea with Potential 45% gainLooking at the chart that gapped down. CVAC has a history of filling the gap. Expecting a gap fill with a risk/reward ratio of 1.57 I am not a financial advisor. Do your own research Buy at 64.30 Sell at 93.70 Stop Loss 44 First Target 75 Second Target 89-94
Long
1
Trading Idea - #CUREVAC (hope for the mutants)THE BIG LONG! Vaccine for the Covid-Mutants! :-) ENTRY: 44.20 EUR TARGET: 90.00 EUR (104 % profit) STOP: 32.40 EUR - This is only an interim analysis result of the CUREVAC Covid vaccince!! - Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Past performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.44Fabulous
Learn more
OANDA
OANDA
Forex
4.53Great
Learn more
FOREX.com
FOREX.com
Forex
4.38Fabulous
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more